The bid came in at between $80 million and $120 million, raising hopes among investors that a sale of the facility may reap ...
D. Boral Capital analyst Jason Kolbert raised the firm’s price target on Veritone (VERI) to $26 from $6 and keeps a Buy rating on the shares. The company’s potential to capture a small piece of the ...
D. Boral Capital LLC acted as Exclusive Financial Advisor to the Company in connection with its direct listing, and Sichenzia Ross Ference Carmel LLP acted as U.S. counsel to D. Boral Capital LLC.
NEW YORK CITY, NEW YORK / ACCESS Newswire / October 27, 2025 / On October 22, 2025, BGIN BLOCKCHAIN LIMITED ("BGIN" or "the Company") (Nasdaq:BGIN), a digital asset technology company with proprietary ...
Fintel reports that on September 25, 2025, D. Boral Capital maintained coverage of Plus Therapeutics (NasdaqCM:PSTV) with a Buy recommendation. Analyst Price Forecast Suggests 2,129.09% Upside As of ...
NEW YORK, NY / ACCESS Newswire / October 17, 2025 / D. Boral Capital, a relationship-driven global investment bank serving middle-market and emerging growth companies, will be a Platinum Sponsor of ...
SGH's industrial equipment businesses, WesTrac Australia and Coates, provide solid revenue and cash flow via exposure to the local government, civil construction, and mining sectors. Wholly owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback